NDC 69968-0731-01 - Neosporin Plus Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69968-0731
- Requested NDC
- 69968-0731-01
- Package NDCs from labels
- 69968-0731-1, 69968-0731-2, 69968-0731-01
- Manufacturer
- Kenvue Brands LLC
- Effective date
- 2025-11-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neosporin Plus Lidocaine - Kenvue Brands LLC | Kenvue Brands LLC | 2025-11-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69968-0731-1 | Neosporin Plus Lidocaine | 14.2 g in 1 TUBE | OINTMENT | 14.2 | 7 | |
| 69968-0731-1 | Neosporin Plus Lidocaine | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 69968-0731-2 | Neosporin Plus Lidocaine | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 69968-0731-2 | Neosporin Plus Lidocaine | 28.3 g in 1 TUBE | OINTMENT | 28.3 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69968-0731 | NEOSPORIN PLUS LIDOCAINE (BACITRACIN, NEOMYCIN, POLYMYXIN B, LIDOCAINE) OINTMENT [KENVUE BRANDS LLC] | 6 | Current NDC, 4 package rows | 20241120_e450b6a1-a8da-e5db-e053-2995a90a0ef0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | M004 89Y4M234ES 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc | 96a7b0a5-030a-42dc-80cd-35c4e9aa1b6d | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc. | 99d9030f-9118-412c-a377-d1df1c8fa723 | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| lidocaine | LIDOCAINE | Asclemed USA, Inc. | 6abf3773-0e60-48b1-9d5c-adc590363d13 | 2021-08-09 | Warnings, Adverse reactions | 98PI200987 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 704a41f5-b109-4c16-8d3e-1495c9917952 | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | fbc12c18-567b-41bc-89d0-efd29616615c | 2021-02-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN, POLYMYXIN B SULFATES, DEXAMETHASONE | Proficient Rx LP | bd9f3220-6d42-4863-aa2a-b17b138d095d | 2021-01-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Trimethoprim sulfate and Polymyxin B sulfate | TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE | Proficient Rx LP | 2c5579eb-ad81-415e-8dcb-9f1c94c897ae | 2021-01-01 | Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Proficient Rx LP | d55f1783-9c49-4f90-9ff8-6f132e7b325e | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Proficient Rx LP | aa7b8a3f-06dd-4190-96a5-f86195bd2197 | 2021-01-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Lidocaine | LIDOCAINE | Proficient Rx LP | f1007717-528a-42e2-94aa-db0edf3bb603 | 2021-01-01 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Asclemed USA, Inc. | c18f0c2b-cd05-4458-888f-47b4a1106937 | 2020-11-03 | Warnings, Adverse reactions | 98PI200987 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Asclemed USA, Inc. | 7c78ec84-8b7c-42f1-a879-3bf27a1daa71 | 2020-10-30 | Boxed warning, Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Resurfix Plus | PETROLATUM | Topiderm, Inc. | f100f43d-6ace-4c3a-9c85-640c0ab2e360 | 2019-11-19 | Warnings | 4T6H12BN9U |
| Lidocaine | LIDOCAINE | Proficient Rx LP | cbf01b82-c43f-4bed-a1df-7569f4816c76 | 2019-11-01 | Warnings, Adverse reactions | 98PI200987 |
| Petrolatum | PETROLATUM | Greenbrier International, Inc. | 91f24a0c-276f-4962-8da8-462b1f42040e | 2019-05-17 | Warnings | 4T6H12BN9U |
| Petrolatum | PETROLATUM | Greenbrier International, Inc. | b8832ee7-3e13-456b-b301-dad7473a032b | 2019-02-04 | Warnings | 4T6H12BN9U |
| BALMEX MULTI-PURPOSE | PETROLATUM | Randob Labs,Ltd. | 83a9ba1a-b708-47e2-a4a3-ef847e1bb792 | 2018-11-13 | Warnings | 4T6H12BN9U |
| Cadira Compliant Blood Stat | LIDOCAINE / PRILOCAINE | Asclemed USA, Inc. | 79a31029-c221-4a4c-8dd9-bf78cbf2a16a | 2018-11-01 | Warnings, Adverse reactions | 98PI200987 |
| LIDO BDK | LIDOCAINE, PRILOCAINE | Asclemed USA, Inc. | 51fd0589-e551-4583-98e1-1e8db19d7e6d | 2018-11-01 | Warnings, Adverse reactions | 98PI200987 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.